These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12880380)

  • 1. Gene therapy for muscular dystrophy - a review of promising progress.
    Gregorevic P; Chamberlain JS
    Expert Opin Biol Ther; 2003 Aug; 3(5):803-14. PubMed ID: 12880380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci.
    Kapsa RM; Wong SH; Bertoncello I; Quigley AF; Williams B; Sells K; Marotta R; Kita M; Simmons P; Byrne E; Kornberg AJ
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S61-6. PubMed ID: 12206798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell and gene therapy in Duchenne muscular dystrophy.
    Morgan JE
    Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic treatments in muscular dystrophies.
    Muntoni F; Wells D
    Curr Opin Neurol; 2007 Oct; 20(5):590-4. PubMed ID: 17885450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
    Benchaouir R; Meregalli M; Farini A; D'Antona G; Belicchi M; Goyenvalle A; Battistelli M; Bresolin N; Bottinelli R; Garcia L; Torrente Y
    Cell Stem Cell; 2007 Dec; 1(6):646-57. PubMed ID: 18371406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in gene therapy of dystrophic heart disease.
    Lai Y; Duan D
    Gene Ther; 2012 Jun; 19(6):678-85. PubMed ID: 22318092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?
    Wells DJ; Wells KE
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S11-22. PubMed ID: 12206790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splice modification to restore functional dystrophin synthesis in Duchenne muscular dystrophy.
    Wilton SD; Fletcher S
    Curr Pharm Des; 2010; 16(8):988-1001. PubMed ID: 20041827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin.
    Scott JM; Li S; Harper SQ; Welikson R; Bourque D; DelloRusso C; Hauschka SD; Chamberlain JS
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S23-9. PubMed ID: 12206791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic approaches to muscular dystrophy.
    Goyenvalle A; Seto JT; Davies KE; Chamberlain J
    Hum Mol Genet; 2011 Apr; 20(R1):R69-78. PubMed ID: 21436158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the use of gene therapy to treat Duchenne muscular dystrophy.
    Jarmin S; Kymalainen H; Popplewell L; Dickson G
    Expert Opin Biol Ther; 2014 Feb; 14(2):209-30. PubMed ID: 24308293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy in large animal models of muscular dystrophy.
    Wang Z; Chamberlain JS; Tapscott SJ; Storb R
    ILAR J; 2009; 50(2):187-98. PubMed ID: 19293461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy research for Duchenne and Becker muscular dystrophies.
    Karpati G; Gilbert R; Petrof BJ; Nalbantoglu J
    Curr Opin Neurol; 1997 Oct; 10(5):430-5. PubMed ID: 9330891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress towards gene therapy for Duchenne muscular dystrophy.
    Hauser MA; Chamberlain JS
    J Endocrinol; 1996 Jun; 149(3):373-8. PubMed ID: 8691095
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy for muscular dystrophies: current status and future prospects.
    Takeda S; Miyagoe-Suzuki Y
    BioDrugs; 2001; 15(10):635-44. PubMed ID: 11604045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotide-mediated gene therapy for muscular dystrophies.
    Rando TA
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S55-60. PubMed ID: 12206797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy in Duchenne muscular dystrophy.
    Inui K; Okada S; Dickson G
    Brain Dev; 1996; 18(5):357-61. PubMed ID: 8891229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne muscular dystrophy.
    Dickson G; Brown SC
    Mol Cell Biol Hum Dis Ser; 1995; 5():261-80. PubMed ID: 9532571
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advances in genome editing technologies for treating muscular dystrophy.].
    Makita Y; Hozumi H; Hotta A
    Clin Calcium; 2017; 27(3):391-399. PubMed ID: 28232654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.